Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 10
1 October 2005
Molecular Cancer Therapeutics Cover Image for Volume 4, Issue 10
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

A role for PKCζ in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin
Caroline Reis; Nicole Giocanti; Christophe Hennequin; Frédérique Mégnin-Chanet; Marie Fernet; Rodolphe Filomenko; Ali Bettaieb; Eric Solary; Vincent Favaudon
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells
Qunzhou Zhang; Xudong Tang; Qing Yi Lu; Zuo Feng Zhang; Jimmy Brown; Anh D. Le
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Sulindac sulfide–induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2
Frank A. Sinicrope; Robert C. Penington
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents
Giulio Francia; Shane K. Green; Guido Bocci; Shan Man; Urban Emmenegger; John M.L. Ebos; Adina Weinerman; Yuval Shaked; Robert S. Kerbel
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells
David L. Morse; Heather Gray; Claire M. Payne; Robert J. Gillies
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer
Curtis Balch; Pearlly Yan; Teresa Craft; Suzanne Young; David G. Skalnik; Tim H-M. Huang; Kenneth P. Nephew
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine
Jody C. Chuang; Christine B. Yoo; Jennifer M. Kwan; Tony W.H. Li; Gangning Liang; Allen S. Yang; Peter A. Jones
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Lindsay Stimson; Martin G. Rowlands; Yvette M. Newbatt; Nicola F. Smith; Florence I. Raynaud; Paul Rogers; Vassilios Bavetsias; Stephen Gorsuch; Michael Jarman; Andrew Bannister; Tony Kouzarides; Edward McDonald; Paul Workman; G. Wynne Aherne
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade
Yijiang Shi; Huajun Yan; Patrick Frost; Joseph Gera; Alan Lichtenstein
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein
Kara R. Jones; David A. Gewirtz; Steven M. Yannone; Shaoming Zhou; David G. Schatz; Kristoffer Valerie; Lawrence F. Povirk
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Counteracting tumor radioresistance by targeting DNA repair
Dörthe Schaue; William H. McBride
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1
Yuseok Moon; Frank G. Bottone, Jr.; Michael F. McEntee; Thomas E. Eling
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
Anders Wallqvist; Ruili Huang; David G. Covell; Anna V. Roschke; Kristen S. Gelhaus; Ilan R. Kirsch
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
The anticancer activity of the fungal metabolite terrecyclic acid A is associated with modulation of multiple cellular stress response pathways
Thomas J. Turbyville; E.M. Kithsiri Wijeratne; Luke Whitesell; A.A. Leslie Gunatilaka
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo
Sheng-Zhou Zhang; Fei-Yan Pan; Jian-Feng Xu; Jun Yuan; Shi-Ying Guo; Gu Dai; Bin Xue; Wei-Gan Shen; Chuan-Jun Wen; Dong-Hong Zhao; Chao-Jun Li
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells
Taishi Hata; Hirofumi Yamamoto; Chew Yee Ngan; Minoru Koi; Akimitsu Takagi; Bazarragchaa Damdinsuren; Masayoshi Yasui; Yujiro Fujie; Takeshi Matsuzaki; Hiromichi Hemmi; Xundi Xu; Kotaro Kitani; Yosuke Seki; Ichiro Takemasa; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
Roohangiz Safaei; Barrett J. Larson; Timothy C. Cheng; Michael A. Gibson; Shinji Otani; Wiltrud Naerdemann; Stephen B. Howell
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells
David Peters; John Freund; Robert L. Ochs
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
Teresa Kosakowska-Cholody; W. Marek Cholody; Anne Monks; Barbara A. Woynarowska; Christopher J. Michejda
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells
Yao-Ting Huang; Shiow-Lin Pan; Jih-Hwa Guh; Ya-Ling Chang; Fang-Yu Lee; Sheng-Chu Kuo; Che-Ming Teng
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Minireview

Using bioinformatics and genome analysis for new therapeutic interventions
David W. Mount; Ritu Pandey
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
GLP-1 Drugs May Play Modest Role in Cancer Prevention
Improved Survival with Diet and Exercise Proven in Phase III Colon Cancer Trials
Outgunning mCRPC with SYNC-T
View more recent articles
Breaking
Tafasitamab Adds Follicular Lymphoma Indication
NextCure Buys ADC for Up to $745 Million
BioNTech to Acquire CureVac for $1.25 Billion
View more recent articles
Research Watch
Multimodal AI Aids Specialist and General Physicians in Skin Cancer Diagnosis
Analysis of the Gut Microbiome Reveals Biomarkers of Colorectal Cancer
Molecular Residual Disease Precedes Disease-Free Survival Events by Months
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept